CIK: 0001646343
Total reported value
$120.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CELG | Celgene CORP | Stock-Other | 14.00% | — | +68.75% | |
| 2 | ✓ | Shire PLC | Stock-Other | 13.57% | — | — | |
| 3 | PFE | Pfizer INC | Stock-Healthcare | 13.39% | — | +32.12% | |
| 4 | ✓ | Stock-Other | 7.64% | -1.96% | +198.91% | ||
| 5 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 6.68% | — | -30.82% | |
| 6 | ✓ | Mylan N V | Stock-Other | 6.53% | +1.63% | NEW | |
| 7 | SNY | Sanofi-adr | Stock-Healthcare | 4.87% | — | — | |
| 8 | ✓ | Horizon Pharma PLC | Stock-Other | 3.78% | — | +52.78% | |
| 9 | SGENEUR | Seagen INC | Stock-Other | 3.74% | — | +14.44% | |
| 10 | LN5 | Lannett Co INC | Stock-Other | 2.79% | — | — | |
| 11 | CNCEEUR | Concert Pharmaceuticals INC | Stock-Other | 2.59% | — | — | |
| 12 | EXEL 4.25 08-15-19 | Exelixis INC | Stock-Healthcare | 2.06% | — | — | |
| 13 | IMGNEUR | Immunogen INC | Stock-Other | 2.01% | — | — | |
| 14 | ADMSEUR | Adamas Pharmaceuticals INC | Stock-Other | 1.75% | — | — | |
| 15 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 1.72% | +3.93% | +55.56% | |
| 16 | QURE | uniQure N.V. | Stock-Other | 1.41% | +1.09% | +219.44% | |
| 17 | EGRX | Eagle Pharmaceuticals INC | Stock-Other | 1.38% | — | — | |
| 18 | IMRX | Immuneering Corporation | Stock-Other | 1.15% | — | +112.84% | |
| 19 | ✓ | Ignyta INC | Stock-Other | 1.05% | — | — | |
| 20 | ✓ | Neuroderm LTD | Stock-Other | 1.02% | — | +45.83% | |
| 21 | ✓ | Advaxis | Stock-Other | 0.94% | — | +80.95% | |
| 22 | FPRX | Five Prime Therapeutics INC | Stock-Other | 0.84% | — | -6.98% | |
| 23 | LION | Lionsgate Studios Corp. | Stock-Other | 0.80% | — | — | |
| 24 | INFIQ | Infinity Pharmaceuticals INC | Stock-Other | 0.79% | — | — | |
| 25 | AERIEUR | Aerie Pharmaceuticals INC | Stock-Other | 0.76% | — | +113.46% | |
| 26 | INSM | Insmed INC | Stock-Healthcare | 0.53% | +0.01% | — | |
| 27 | PGNXUSD | Progenics Pharmaceuticals | Stock-Other | 0.43% | — | — | |
| 28 | CTH | Cynapsus Therapeutics INC | Stock-Other | 0.42% | — | — | |
| 29 | ✓ | Biopharmx | Stock-Other | 0.39% | — | — | |
| 30 | ✓ | Tobira Therapeutics Inc | Stock-Other | 0.38% | — | +28.57% | |
| 31 | ✓ | Xenoport INC | Stock-Other | 0.37% | — | — | |
| 32 | NERVGBP | Minerva Neurosciences INC | Stock-Other | 0.22% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | +3.6% | +198.91% | Add | |
| 2 | QURE | uniQure N.V. | +0.6% | +219.44% | Add |
| 3 | CELG | Celgene CORP | +0.4% | +68.75% | Add |
| 4 | ✓ | Advaxis | +0.2% | +80.95% | Add |
| 5 | IMRX | Immuneering Corporation | 0% | +112.84% | Add |
| 6 | ✓ | Neuroderm LTD | -0.1% | +45.83% | Add |
| 7 | ✓ | Horizon Pharma PLC | -0.7% | +52.78% | Add |
| 8 | LION | Lionsgate Studios Corp. | -0.9% | — | Unchanged |
| 9 | PFE | Pfizer INC | -1.7% | +32.12% | Add |
| 10 | SGENEUR | Seagen INC | -2% | +14.44% | Add |
| 11 | CNCEEUR | Concert Pharmaceuticals INC | -2.3% | — | Unchanged |
| 12 | BMY | Bristol-myers Squibb Co | -7.6% | -30.82% | Trim |
| 13 | ✓ | Shire PLC | — | NEW | New buy |
| 14 | ✓ | Mylan N V | — | NEW | New buy |
| 15 | MRK | Merck & Co. INC. | — | EXIT | Sold out |
| 16 | SNY | Sanofi-adr | — | NEW | New buy |
| 17 | ABBV | Abbvie INC | — | EXIT | Sold out |
| 18 | LN5 | Lannett Co INC | — | NEW | New buy |
| 19 | EXEL 4.25 08-15-19 | Exelixis INC | — | NEW | New buy |
| 20 | ALDR1EUR | Alder Biopharmaceuticals INC | — | EXIT | Sold out |
| 21 | IMGNEUR | Immunogen INC | — | NEW | New buy |
| 22 | ADMSEUR | Adamas Pharmaceuticals INC | — | NEW | New buy |
| 23 | EGRX | Eagle Pharmaceuticals INC | — | NEW | New buy |
| 24 | ✓ | Ignyta INC | — | NEW | New buy |
| 25 | ✓ | Cti Biopharma CORP | — | EXIT | Sold out |
| 26 | INFIQ | Infinity Pharmaceuticals INC | — | NEW | New buy |
| 27 | HRTX | Heron Therapeutics INC | — | EXIT | Sold out |
| 28 | DRRXEUR | Durect Corporation | — | EXIT | Sold out |
| 29 | ✓ | Sciclone Pharmaceuticals INC | — | EXIT | Sold out |
| 30 | INSM | Insmed INC | — | NEW | New buy |
| 31 | ✓ | Inotek Pharmaceuticals CORP | — | EXIT | Sold out |
| 32 | ✓ | Oncothyreon INC | — | EXIT | Sold out |
| 33 | PGNXUSD | Progenics Pharmaceuticals | — | NEW | New buy |
| 34 | ✓ | Inovio Pharmaceuticals INC | — | EXIT | Sold out |
| 35 | CTH | Cynapsus Therapeutics INC | — | NEW | New buy |
| 36 | ✓ | Biopharmx | — | NEW | New buy |
| 37 | ✓ | Vitae Pharmaceuticals INC | — | EXIT | Sold out |
| 38 | ✓ | Xenoport INC | — | NEW | New buy |
| 39 | GWPH | Gw Pharmaceuticals LTD | — | EXIT | Sold out |
| 40 | RDHLGBP | Redhill Biopharma Ltd-sp Adr | — | EXIT | Sold out |
| 41 | ✓ | Kamada LTD | — | EXIT | Sold out |
| 42 | ✓ | Pronai Therapeutics INC | — | EXIT | Sold out |
| 43 | ✓ | Peregrine Pharmaceuticals In | — | EXIT | Sold out |
| 44 | SNY | Sanofi | — | EXIT | Sold out |
| 45 | ✓ | Scynexis INC Com New | — | EXIT | Sold out |
| 46 | AAAPGBP | Advanced Accelerator App-adr | — | EXIT | Sold out |
| 47 | NEOS | Neos Therapeutics INC | — | EXIT | Sold out |
| 48 | MRNSUSD | Marinus Pharmaceuticals INC | — | EXIT | Sold out |
| 49 | ✓ | — | EXIT | Sold out | |
| 50 | ✓ | Celator Pharmaceuticals INC | — | EXIT | Sold out |